Journal of Stem Cell Research & Therapy

2^nd International Conference and Exhibition on Cell & Gene Therapy

October 23-25, 2013 Holiday Inn Orlando International Airport, Orlando, FL, USA

Scientific Tracks Abstracts

• Systemic delivery of thiol-specific antioxidant hPRDX6 gene by AAV8 inhibits atherogenesis in LDLR KO mice on HCD

  Paul L. Hermonat, Hongqing Zhu, Maohua Cao and Karl D. Straub

  PDF HTML

• Targeted knock-up of endogenous genes using a long non-coding RNA chaperone to improve translation efficiency

  Michael H. Jones

  PDF HTML

• Gene therapy for autoimmune diseases: Preclinical and clinical studies

  Paul D. Robbins

  PDF HTML

• The impact of leptin on stem cell differentiation towards osteoblasts: Assessed by an osteo/ chondro microRNA signature

  Jan Oxholm Gordeladze, Janne E. Reseland and Unni Syversen

  PDF HTML

• Stress related plasma proteins & UCB stem cell trafficking

  Mary J. Laughlin

  PDF HTML

• Adipose derived stem cells as treatment for chronic wounds

  Hilal Arnouk

  PDF HTML

• PET imaging of gene expression in primate model of Parkinson?s disease

  Hideo Tsukada

  PDF HTML

• MicroRNAs in the therapy of myocardial infarction

  Peifeng Li

  PDF HTML

• Optimizing the microenvironment of human pluripotent stem cells to maximize our understanding in their biology and their potential in regenerative medicine

  Luis G. Villa-Diaz

  PDF HTML

• JVS-100: A non-viral gene therapy encoding stromal cell-derived factor-1 for treatment of ischemic cardiovascular disease

  Joseph Pastore

  PDF HTML

• Biofunctionalization of blood contacting surfaces with homing factor mimetic molecules for induction of in vivo stem cell seeding

  Meltem Avci-Adali

  PDF HTML

• Sex and microRNA in cancer stem/progenitor cells

  Wen-Lung Ma, Wei-Min Chung, Wei-Chun Chang, Lumin Chen, Ying-Yi Chang and Yao-Ching Hung

  PDF HTML

• Lentiviral-based anti-HIV therapeutic vaccine: Design, preclinical studies and phase I/II clinical trial preliminary results

  Cecile Bauche

  PDF HTML

• Gene expression program of neural stem cells

  Mojgan Rastegar

  PDF HTML

• Multiparametricimmunophenotyping of human hematopoietic stem cells and progenitor cells by flow cytometry

  Phil Paul

  PDF HTML

• Large scale transplantable liver graft using decellularized whole-organ scaffold

  Hiroshi Yagi

  PDF HTML

• Application of stem cells in brain diseases: Lessons from stroke and amyotrophic lateral sclerosis

  Dinko Mitrecic

  PDF HTML

• The metastability of multipotent hematopoietic cells is attenuated by bone marrow niche cells

  Wendy W. Weston

  PDF HTML

• The diverse roles of nuclear receptors in the regulation of embryonic stem cell pluripotency

  Austin J. Cooney and Ryan T. Wagner

  PDF HTML

• Stem cell therapy for COPD

  Burton Feinerman

  PDF HTML

• Application of genomic sequencing for understanding tumors

  Scott Kahn

  PDF HTML

• FoxM1 transcription factor as a potential target for therapeutic intervention in breast cancer

  Gabriela Nestal de Moraes

  PDF HTML

• New histone deacetylase inhibitors upregulate PTEN expression

  Chiara Zagni

  PDF HTML

• Combined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancer

  Xuejun Dong, Mingfeng Yang, He Sun, Juan LU, Zhuan Zheng, Zhiguo Li and Li Zhong

  PDF HTML

• Selective killing of RAD54B-deficient colorectal cancer cells through SOD1 inhibition

  Kirk J. McManus, Babu V. Sajesh and Zelda Lichtensztejn

  PDF HTML

• New approaches to personalised cancer care

  Marija Krstic-Demonacos

  PDF HTML

• Obesity and chemotherapy resistance: The nanoparticle approach

  Rebecca E. De Angel

  PDF HTML

• Better manufacturing practice for cell therapies

  Kevin Murray

  PDF HTML

• The laminin protein family - The key to reliable stem cell expansion and primary cell culture

  Louise Sivertssson

  PDF HTML

• Nano methods to target cancer cells by using ultrasound targeted nano-emulsions contrast

  Vikas Leelavati Balasaheb Jadhav

  PDF HTML

• Cell content and viability assessments for human cell therapy products: Towards effective development of suitable assays and controls

  Brent L. Atkinson

  PDF HTML

• Novel therapeutic nanoparticles for in vivo delivery of low dose siRNA in liver cells and for the treatment of liver fibrosis associated non-alcoholic steatohepatitis

  Xavier de Mollerat du Jeu, Akiko Eguchi, Andronikou Nektaria1, Ariel E. Feldstein and Peter Welch

  PDF HTML

• Treatment of PTEN-positive tumors with small interfering RNA targeting the mammalian target of rapamycin

  Tomohiro Asai and Naoto Oku

  PDF HTML

• A phase one, open label, single arm study to demonstrate the safety of the Antria cell preparation process during facial fat grafting assisted with autologous, adipose-derived stromal vascular fraction (SVF)

  Shah Rahimian

  PDF HTML

• Ethos, ethics, bioethics and stem cells. Is everything allowed?

  Vassilis Katsares

  PDF HTML

• The challenges and possible solutions for transferring cell therapy from the bench to the industry, quality, cost and manufacturing efficiency

  Ohad Karnieli

  PDF HTML